An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma
Crossref DOI link: https://doi.org/10.1038/s41598-024-53172-3
Published Online: 2024-03-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Shuqing
Yi, Zhihui
Li, Mingqing
Zhu, Zhiling
Text and Data Mining valid from 2024-03-11
Version of Record valid from 2024-03-11
Article History
Received: 26 October 2023
Accepted: 29 January 2024
First Online: 11 March 2024
Competing interests
: The authors declare no competing interests.